Logo image
An interferon-beta promoter reporter assay for high throughput identification of compounds against multiple RNA viruses
Journal article   Open access   Peer reviewed

An interferon-beta promoter reporter assay for high throughput identification of compounds against multiple RNA viruses

Fang Guo, Xuesen Zhao, Tina Gill, Yan Zhou, Matthew Campagna, Lijuan Wang, Fei Liu, Pinghu Zhang, Laura DiPaolo, Yanming Du, …
Antiviral research, v 107(1), pp 56-65
01 Jul 2014
PMID: 24792753
url
https://doi.org/10.1016/j.antiviral.2014.04.010View
Published, Version of Record (VoR)Open Access (License Unspecified) Open

Abstract

Life Sciences & Biomedicine Pharmacology & Pharmacy Science & Technology Virology
Virus infection of host cells is sensed by innate pattern recognition receptors (PRRs) and induces production of type I interferons (IFNs) and other inflammatory cytokines. These cytokines orchestrate the elimination of the viruses but are occasionally detrimental to the hosts. The outcomes and pathogenesis of viral infection are largely determined by the specific interaction between the viruses and their host cells. Therefore, compounds that either inhibit viral infection or modulate virus-induced cytokine response should be considered as candidates for managing virus infection. The aim of the study was to identify compounds in both categories, using a single cell-based assay. Our screening platform is a HEK293 cell-based reporter assay where the expression of a firefly luciferase is under the control of a human IFN-beta promoter. We have demonstrated that infection of the reporter cell line with a panel of RNA viruses activated the reporter gene expression that correlates quantitatively with the levels of virus replication and progeny virus production, and could be inhibited in a dose-dependent manner by known antiviral compound or inhibitors of PRR signal transduction pathways. Using Dengue virus as an example, a pilot screening of a small molecule library consisting of 26,900 compounds proved the concept that the IFN-beta promoter reporter assay can serve as a convenient high throughput screening platform for simultaneous discovery of antiviral and innate immune response modulating compounds. A representative antiviral compound from the pilot screening, 1-(6-ethoxybenzo[d]thiazol-2-yl)-3-(3-methoxyphenyl) urea, was demonstrated to specifically inhibit several viruses belonging to the family of flaviviridae. (C) 2014 Elsevier B.V. All rights reserved.

Metrics

15 Record Views
15 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Pharmacology & Pharmacy
Virology
Logo image